| Reference : The antiangiogenic 16K prolactin disturbs functional tumor neovascularization by affecti... |
| Scientific congresses and symposiums : Poster | |||
| Human health sciences : Multidisciplinary, general & others | |||
| http://hdl.handle.net/2268/109047 | |||
| The antiangiogenic 16K prolactin disturbs functional tumor neovascularization by affecting vessel maturation | |
| English | |
Nguyen, Ngoc-Quynh-Nhu [Université de Liège - ULg > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire > > >] | |
| Castermans, Karolien [Université de Liège - ULg > Département des sciences de la vie > Giga-R: Biologie et Génétique moléculaire > >] | |
| Berndt, Sarah [Université de Liège - ULg > Département des sciences cliniques > Giga-R: Labo de biologie des tumeurs et du développement > >] | |
Herkenne, Stéphanie [Université de Liège - ULg > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire >] | |
Tabruyn, Sébastien [Université de Liège - ULg > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire >] | |
Blacher, Silvia [Université de Liège - ULg > Département des sciences cliniques > Labo de biologie des tumeurs et du développement > > >] | |
Lion, Michelle [Université de Liège - ULg > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire >] | |
Noël, Agnès [Université de Liège - ULg > Département des sciences biomédicales et précliniques > Biologie cellulaire et moléculaire appliquée à l'homme >] | |
Martial, Joseph [Université de Liège - ULg > Département des sciences de la vie > Département des sciences de la vie >] | |
Struman, Ingrid [Université de Liège - ULg > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire >] | |
| May-2011 | |
| International | |
| 4th International Meeting on Angiogenesis | |
| Amsterdam | |
| The Netherlands | |
| [en] 16K hPRL ; angiogenesis ; vessel maturation | |
| [en] 16K hPRL, the antiangiogenic 16-kDa N-terminal fragment of human prolactin was shown to prevent tumor growth and metastasis by modifying tumor vessel morphology. Here we investigated the effect of 16K hPRL on tumor vessel maturation and on the related signaling pathways. We show that 16K hPRL treatment leads, in a murine B16-F10 tumor model, to a dysfunctional tumor vasculature with reduced pericyte coverage, and disruption of the PDGF-B/PDGFR-B, Ang/Tie2, and Delta/Notch pathways. In an aortic ring assay, 16K hPRL impairs endothelial cell and pericyte outgrowth from the vascular ring. In addition, 16K hPRL prevents pericyte migration to endothelial cells. This event was independent of a direct inhibitory effect of 16K hPRL on pericyte viability, proliferation, or migration. In endothelial cell-pericyte cocultures, we found 16K hPRL to disturb Notch signaling, this being the first time such an effect is observed with an endogenous antiangiogenic agent. These findings provide new insights into the mechanisms of 16K hPRL action and highlight its potential for use in anticancer therapy. | |
| Researchers ; Professionals | |
| http://hdl.handle.net/2268/109047 |
There is no file associated with this reference.
All documents in ORBi are protected by a user license.